Teaching Old Drugs New Tricks: Statins for COVID-19?

The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajgenbaum, David C., Rader, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402379/
https://www.ncbi.nlm.nih.gov/pubmed/32755604
http://dx.doi.org/10.1016/j.cmet.2020.07.006
_version_ 1783566746120093696
author Fajgenbaum, David C.
Rader, Daniel J.
author_facet Fajgenbaum, David C.
Rader, Daniel J.
author_sort Fajgenbaum, David C.
collection PubMed
description The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.
format Online
Article
Text
id pubmed-7402379
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74023792020-08-05 Teaching Old Drugs New Tricks: Statins for COVID-19? Fajgenbaum, David C. Rader, Daniel J. Cell Metab Preview The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials. Elsevier Inc. 2020-08-04 2020-08-04 /pmc/articles/PMC7402379/ /pubmed/32755604 http://dx.doi.org/10.1016/j.cmet.2020.07.006 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preview
Fajgenbaum, David C.
Rader, Daniel J.
Teaching Old Drugs New Tricks: Statins for COVID-19?
title Teaching Old Drugs New Tricks: Statins for COVID-19?
title_full Teaching Old Drugs New Tricks: Statins for COVID-19?
title_fullStr Teaching Old Drugs New Tricks: Statins for COVID-19?
title_full_unstemmed Teaching Old Drugs New Tricks: Statins for COVID-19?
title_short Teaching Old Drugs New Tricks: Statins for COVID-19?
title_sort teaching old drugs new tricks: statins for covid-19?
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402379/
https://www.ncbi.nlm.nih.gov/pubmed/32755604
http://dx.doi.org/10.1016/j.cmet.2020.07.006
work_keys_str_mv AT fajgenbaumdavidc teachingolddrugsnewtricksstatinsforcovid19
AT raderdanielj teachingolddrugsnewtricksstatinsforcovid19

Ejemplares similares